Fiasp (insulin aspart) 100 units/mL solution for injection (all formulations)

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
06 September 2019

Abstract

SPC updated to include new paediatric indication. Fiasp (insulin aspart) is licensed for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.